Home > Medical Research Archives > Issue 149 > Pulsed Electromagnetic Field Therapy (Seqex, Theta) Promotes Well-being as assessed by Heart Rate Variability: A Pilot Study
Published in the Medical Research Archives
Oct 2022 Issue
Pulsed Electromagnetic Field Therapy (Seqex, Theta) Promotes Well-being as assessed by Heart Rate Variability: A Pilot Study
Published on Oct 31, 2022
DOI
Abstract
Frequency therapy, in the form of pulsed electromagnetic fields, is becoming increasingly popular within the scientific/medical community as is heart rate variability for assessing wellness. These two techniques were combined to determine if a particular pulsed electromagnetic field treatment (Seqex, Theta) had any beneficial effects (based on Brain Tap HRV) on 20 volunteers ranging in age from 21-81. Treatment consisted of a 36-minute exposure to 4–8 Hz with a magnetic flux density between 12 to 68 mG and several proprietary waveforms. Treatment was conducted at a wellness clinic that had low levels of electromagnetic fields/radiation and heart rate variability was tested immediately before and immediately following treatment. Significant benefits were documented for 72% of the participants and these were associated with reduced stress and a lower biological age (vs. chronological age) as indicators on Brain Tap HRV. Indices for cardiovascular health; LF/HF balance, neurohormonal regulation and psychoemotional state all improved overall as did energy resources and energy balance (catabolic vs. anabolic). Individuals who believed they were sensitive to electromagnetic fields (i.e. had electrohypersensitivity) also improved. Some of the beneficial results persisted over a 24-hour period. Despite this positive outcome, 28% of the participants either showed no objective change or were worse (based on heart rate variability) immediately following treatment. We conclude that pulsed electromagnetic field treatments may be highly beneficial even among those who have electrohypersensitivity resulting in reduced stress and improved homeostasis. However, treatments should be provided in an electromagnetic clean environment for optimal results and objective testing with heart rate variability, or some other assessment tool, should be used to ensure that the patient is receiving a treatment that is beneficial.
Author info
Author Area
Have an article to submit?
Submission Guidelines
Submit a manuscript
Become a member